Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation.
Liuzzo G, Santamaria M, Biasucci LM, Narducci M, Colafrancesco V, Porto A, Brugaletta S, Pinnelli M, Rizzello V, Maseri A, Crea F. Liuzzo G, et al. Among authors: colafrancesco v. J Am Coll Cardiol. 2007 Jan 16;49(2):185-94. doi: 10.1016/j.jacc.2006.07.071. Epub 2006 Dec 29. J Am Coll Cardiol. 2007. PMID: 17222729 Free article.
Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.
Villoslada P, Vila G, Colafrancesco V, Moreno B, Fernandez-Diez B, Vazquez R, Pertsovskaya I, Zubizarreta I, Pulido-Valdeolivas I, Messeguer J, Vendrell-Navarro G, Frade JM, López-Sánchez N, Teixido M, Giralt E, Masso M, Dugas JC, Leonoudakis D, Lariosa-Willingham KD, Steinman L, Messeguer A. Villoslada P, et al. Among authors: colafrancesco v. Neurotherapeutics. 2019 Jul;16(3):808-827. doi: 10.1007/s13311-019-00717-4. Neurotherapeutics. 2019. PMID: 30815844 Free PMC article.
Comparison of the Efficacy of Brolucizumab with Natural Disease Progression in Wet AMD Using Clinical Data from the Phase III HAWK and HARRIER Trials and Modelled Placebo Data.
Agostini H, Mulyukov Z, Tsilimbaris M, Calvo P, Bucher F, Gaucher D, Pigeolet E, Colafrancesco V, Clemens A. Agostini H, et al. Among authors: colafrancesco v. Curr Eye Res. 2020 Oct;45(10):1298-1301. doi: 10.1080/02713683.2020.1731832. Epub 2020 Feb 26. Curr Eye Res. 2020. PMID: 32065533 Clinical Trial.
11 results